System evaluation on Ginkgo Biloba extract in the treatment of acute cerebral infarction.
10.11817/j.issn.1672-7347.2015.10.007
- Author:
Lin WANG
1
;
Tao ZHANG
2
;
Kezhen BAI
2
Author Information
1. Department of Psychiatric, the Affiliated Hospital of Luzhou Medical College, Luzhou Sichuan 646000, China nnjj0011@163.com.
2. Department of Psychiatric, the Affiliated Hospital of Luzhou Medical College, Luzhou Sichuan 646000, China.
- Publication Type:Journal Article
- MeSH:
Cerebral Infarction;
drug therapy;
Ginkgo biloba;
chemistry;
Humans;
Phytotherapy;
Plant Extracts;
therapeutic use;
Randomized Controlled Trials as Topic
- From:
Journal of Central South University(Medical Sciences)
2015;40(10):1096-1102
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the effect and safety of Ginkgo Biloba extract on the treatment of acute cerebral infarction.
METHODS:The Database of Wanfang, China National Knowledge Infrastructure (CNKI) and VIPU were screened for literatures regarding Ginkgo Biloba extract in the treatment of acute cerebral infarction, including the clinical randomized controlled trials. Meta-analysis based on the Revman 4.2 system was performed.
RESULTS:Compared with the control group, treatment with Ginkgo Biloba extract enhanced efficacy in the treatment of acute cerebral infarction (OR: 1.60-5.53), which displayed an improved neural function defect score [WMD -3.12 (95%CI: -3.96- -2.28)].
CONCLUSION:Ginkgo Biloba extract is beneficial to the improvement of neurological function in patients with acute cerebral infarction and it is safe for patients.
